Novo Nordisk’s ‘Semaglutide’ gains weight against Eli Lilly in battle for market share
Mumbai: Danish drugmaker Novo Nordisk‘s diabetes and weight-loss molecule semaglutide is gaining ground on Eli Lilly‘s tirzepatide in…
Browsing Tag